Dark Cloud Lifts On Sophiris Bio's Localized Prostate Cancer Injectable Topsalysin

Phase IIb study death after intratumoral injection was unrelated to study drug, San Diego-based start-up says.

More From BioPortfolio on "Dark Cloud Lifts On Sophiris Bio's Localized Prostate Cancer Injectable Topsalysin"